Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
5.48
-0.05 (-0.90%)
At close: Sep 10, 2025, 4:00 PM
5.56
+0.08 (1.46%)
After-hours: Sep 10, 2025, 7:53 PM EDT
Owens & Minor Market Cap
Owens & Minor has a market cap or net worth of $423.30 million as of September 10, 2025. Its market cap has decreased by -64.92% in one year.
Market Cap
423.30M
Enterprise Value
2.49B
1-Year Change
-64.92%
Ranking
Category
Stock Price
$5.48
Market Cap Chart
Since December 1, 1998, Owens & Minor's market cap has decreased from $545.50M to $423.30M, a decrease of -22.40%. That is a compound annual growth rate of -0.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 427.20M | -57.61% |
Dec 31, 2024 | 1.01B | -31.64% |
Dec 29, 2023 | 1.47B | -0.99% |
Dec 30, 2022 | 1.49B | -54.64% |
Dec 31, 2021 | 3.28B | 65.06% |
Dec 31, 2020 | 1.99B | 512.03% |
Dec 31, 2019 | 324.90M | -17.58% |
Dec 31, 2018 | 394.20M | -65.91% |
Dec 29, 2017 | 1.16B | -46.73% |
Dec 30, 2016 | 2.17B | -4.06% |
Dec 31, 2015 | 2.26B | 2.16% |
Dec 31, 2014 | 2.21B | -4.03% |
Dec 31, 2013 | 2.31B | 27.67% |
Dec 31, 2012 | 1.81B | 2.54% |
Dec 30, 2011 | 1.76B | -5.43% |
Dec 31, 2010 | 1.86B | 3.71% |
Dec 31, 2009 | 1.80B | 15.37% |
Dec 31, 2008 | 1.56B | -10.09% |
Dec 31, 2007 | 1.73B | 37.84% |
Dec 29, 2006 | 1.26B | 14.42% |
Dec 30, 2005 | 1.10B | -1.08% |
Dec 31, 2004 | 1.11B | 30.09% |
Dec 31, 2003 | 853.70M | 52.42% |
Dec 31, 2002 | 560.10M | -10.60% |
Dec 31, 2001 | 626.50M | 6.66% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.84B |
Johnson & Johnson | 429.72B |
AbbVie | 375.50B |
UnitedHealth Group | 285.64B |
AstraZeneca | 253.68B |
Novartis AG | 252.55B |
Novo Nordisk | 244.67B |
Abbott Laboratories | 231.38B |